Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H23N3OS.2ClH |
Molecular Weight | 366.35 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CCN(CC)CCOC1=CC=C2N=C(SC2=C1)N(C)C
InChI
InChIKey=FZNXAQMQVKBXDR-UHFFFAOYSA-N
InChI=1S/C15H23N3OS.2ClH/c1-5-18(6-2)9-10-19-12-7-8-13-14(11-12)20-15(16-13)17(3)4;;/h7-8,11H,5-6,9-10H2,1-4H3;2*1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C15H23N3OS |
Molecular Weight | 293.428 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
5 % 3 times / day steady, topical Dose: 5 %, 3 times / day Route: topical Route: steady Dose: 5 %, 3 times / day Sources: |
unhealthy, 4 weeks n = 1 Health Status: unhealthy Condition: ringworm Age Group: 4 weeks Sex: F Population Size: 1 Sources: |
Disc. AE: Convulsions... AEs leading to discontinuation/dose reduction: Convulsions (1 patient) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Convulsions | 1 patient Disc. AE |
5 % 3 times / day steady, topical Dose: 5 %, 3 times / day Route: topical Route: steady Dose: 5 %, 3 times / day Sources: |
unhealthy, 4 weeks n = 1 Health Status: unhealthy Condition: ringworm Age Group: 4 weeks Sex: F Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
A survey of reported synthesis of methaqualone and some positional and structural isomers. | 2001 Nov 1 |
|
Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. | 2002 Nov |
|
Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches. | 2009 Jan 10 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/13673207
Tnichophyton purpureum was treated by various concentrations of Diamthazole (Asterol) in both sugar-free and sugar-containing media. The drug concentration varied from 0.39-6.24 ug/ml. 50% of growth inhibition was achieved at 1 ug/ml in sugar-containing media and at 0.25 ug/ml in sugar-free media.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:53 GMT 2023
by
admin
on
Fri Dec 15 15:02:53 GMT 2023
|
Record UNII |
3LF09TBB5W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT002640
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
m681
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
3LF09TBB5W
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
136-96-9
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
300000036008
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
8707
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
205-270-5
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
C004723
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
DTXSID40159627
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |